BIRLAMCHI OCHIQ BURCHAKLI GLAUKOMA EPIDEMIOLOGIYASI VA XAVF OMILLARI (ADABIYOTLAR SHARHI)

Authors

  • Nazirdjonov Muradil Abdusaidovich Ilmiy rahbar:
  • Xolmatov Axrorjon Rahbarjon oʻgʻli Central Asian Medical University xalqaro tibbiyot universiteti oftalmologiya yoʻnalish klinik ordinatori
  • Jumanboyev Diyorbek Shukurjon oʻgʻli Central Asian Medical University xalqaro tibbiyot universiteti oftalmologiya yoʻnalish klinik ordinatori

Keywords:

birlamchi ochiq burchakli glaukoma, epidemiologiya, tarqalish, xavf omillari, koʻz ichi bosimi, koʻrlik.

Abstract

Ushbu tezisda populyatsion tadqiqotlar, meta-tahlillar va yirik randomizatsiyalangan klinik tadqiqotlar maʼlumotlari asosida birlamchi ochiq burchakli glaukomaning tarqalishi, koʻrlik tuzilmasidagi oʻrni hamda asosiy xavf omillari tahlil qilingan.

References

1.GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight // Lancet Global Health. – 2021. – Vol. 9, №2. – P. e144–e160.

2.Weinreb R.N., Aung T., Medeiros F.A. The pathophysiology and treatment of glaucoma: a review // JAMA. – 2014. – Vol. 311, №18. – P. 1901–1911.

3.Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020 // British Journal of Ophthalmology. – 2006. – Vol. 90, №3. – P. 262–267.

4.Tham Y.C., Li X., Wong T.Y. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis // Ophthalmology. – 2014. – Vol. 121, №11. – P. 2081–2090.

5.Kass M.A., Heuer D.K., Higginbotham E.J. et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma // Archives of Ophthalmology. – 2002. – Vol. 120, №6. – P. 701–713.

6.Leske M.C., Heijl A., Hussein M. et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial // Archives of Ophthalmology. – 2003. – Vol. 121, №1. – P. 48–56.

7.Gordon M.O., Beiser J.A., Brandt J.D. et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma // Archives of Ophthalmology. – 2002. – Vol. 120, №6. – P. 714–720.

8.Wolfs R.C., Klaver C.C., Ramrattan R.S. et al. Genetic risk of primary open-angle glaucoma: population-based familial aggregation study // Archives of Ophthalmology. – 1998. – Vol. 116, №12. – P. 1640–1645.

9.Marcus M.W., de Vries M.M., Junoy Montolio F.G., Jansonius N.M. Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis // Ophthalmology. – 2011. – Vol. 118, №10. – P. 1989–1994.

Downloads

Published

2026-09-28

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.